Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03439696
Other study ID # 106-067-F
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 22, 2018
Est. completion date April 30, 2019

Study information

Verified date February 2021
Source National Taiwan University Hospital Hsin-Chu Branch
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators' study aims is to evaluate the safety and efficacy of uniportal VATS under assistance of needlescopic instruments through additional 2-3 mm ports compared to conventional uniportal VATS in patients with lung lesions.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date April 30, 2019
Est. primary completion date December 12, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: Lung or mediastinal disease requiring thoracoscopic surgery Exclusion Criteria: Thoracoscopic esophagectomy Decortication for empyema

Study Design


Intervention

Procedure:
Thoracoscopic surgery
Video-assisted thoracoscopic surgery for pulmonary or mediastinal lesions.

Locations

Country Name City State
Taiwan National Taiwan University Hospital, Hsin-Chu Branch Taipei Hsin-Chu County

Sponsors (1)

Lead Sponsor Collaborator
IRB of NTUH Hsin-Chu Branch

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain scale POD 3 Post-operative day 3 pain scale documented using Visual Analogue Scale (VAS) 3 days
Primary Pain scale POD 5 Post-operative day 5 pain scale documented using Visual Analogue Scale (VAS) 5 days
Primary Hospital stay Post-operative hospital stay 14 days
Primary Post-operative 3 month neuralgia Out patient documented using PainDETECT questionnaire (PD-Q) 3 months
Primary Post-operative 6 month neuralgia Out patient documented using PainDETECT questionnaire (PD-Q) 6 months
Secondary Cost Total hospital cost 14 days
Secondary Surgical time Time spend in surgery 1 day
Secondary Surgical bleeding Blood loss during operation 1 day
Secondary Opioid using dosage Total opioid equivalent dose used during post-operative course 14 days
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk